Development and Validation of an Efficient and Highly Sensitive Enzyme-Linked Immunosorbent Assay for Alemtuzumab Quantification in Human Serum and Plasma.
Ther Drug Monit
; 45(1): 79-86, 2023 02 01.
Article
in En
| MEDLINE
| ID: mdl-36150715
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Graft vs Host Disease
/
Antibodies, Monoclonal
Type of study:
Diagnostic_studies
/
Guideline
Limits:
Humans
Language:
En
Journal:
Ther Drug Monit
Year:
2023
Document type:
Article
Affiliation country:
Países Bajos
Country of publication:
Estados Unidos